Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRC
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2398166
下载链接
链接失效反馈官方服务：
资源简介：
This was a single-arm, prospective study to investigate the safety of cetuximab in combination with trifluridin tipiracil (TAS-102) in the third-line treatment of Chinese patients with RAS wild-type mCRC.
创建时间：
2022-09-15
